{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:45:45Z","timestamp":1791456345391,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005294","name":"Massachusetts General Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005294","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","annallergy.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of Allergy, Asthma & Immunology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.anai.2024.01.009","type":"journal-article","created":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T17:38:23Z","timestamp":1705599503000},"page":"630-636.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The impact of COVID-19 vaccine reactions on secondary vaccine hesitancy"],"prefix":"10.1016","volume":"132","author":[{"given":"Esther E.","family":"Freeman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis G.","family":"Strahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam R.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allen D.","family":"Judd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Upeka","family":"Samarakoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4773-9817","authenticated-orcid":false,"given":"Kimberly G.","family":"Blumenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.anai.2024.01.009_bib0001","unstructured":"World Health Organization. WHO Coronavirus (COVID-19) Dashboard. Available at: https:\/\/covid19.who.int\/. Accessed January 23, 2024."},{"key":"10.1016\/j.anai.2024.01.009_bib0002","unstructured":"Centers for Disease Control and Prevention. COVID Data Tracker: COVID-19 vaccinations in the United States. Department of Health and Human Services. Available at: https:\/\/covid.cdc.gov\/covid-data-tracker\/#vaccinations_vacc-total-admin-rate-total. Accessed January 23, 2024."},{"key":"10.1016\/j.anai.2024.01.009_bib0003","unstructured":"Lopes L, Schumacher S, Sparks G, Presaido M, Hamel L, Brodie M. KFF COVID-19 vaccine monitor: December 2022. KAISER FAMILY FOUNDATION. Available at: https:\/\/www.kff.org\/coronavirus-covid-19\/poll-finding\/kff-covid-19-vaccine-monitor-december-2022\/. Accessed January 23, 2024."},{"issue":"11","key":"10.1016\/j.anai.2024.01.009_bib0004","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.3390\/vaccines9111286","article-title":"Willingness to receive the booster COVID-19 vaccine dose in Poland","volume":"9","author":"Rzymski","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.anai.2024.01.009_bib0005","unstructured":"European Centre for Disease Prevention and Control. Partial COVID-19 Vaccination, Vaccination Following SARS-CoV-2 Infection and Heterologous Vaccination Schedule: Summary of Evidence. Available at: https:\/\/www.ecdc.europa.eu\/en\/publications-data\/partial-covid-19-vaccination-summary. Accessed January 23, 2024."},{"issue":"3","key":"10.1016\/j.anai.2024.01.009_bib0006","doi-asserted-by":"crossref","first-page":"479","DOI":"10.3390\/vaccines10030479","article-title":"Evaluating COVID-19 booster vaccination strategies in a partially vaccinated population: a modeling study","volume":"10","author":"Massonnaud","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"7","key":"10.1016\/j.anai.2024.01.009_bib0007","doi-asserted-by":"crossref","first-page":"255","DOI":"10.15585\/mmwr.mm7107e2","volume":"71","author":"Ferdinands","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.anai.2024.01.009_bib0008","unstructured":"World Health Organization. Ten threats to global health in 2019. Available at: https:\/\/www.who.int\/news-room\/spotlight\/ten-threats-to-global-health-in-2019. Accessed January 23, 2024."},{"issue":"8","key":"10.1016\/j.anai.2024.01.009_bib0009","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10654-020-00671-y","article-title":"Vaccine hesitancy: the next challenge in the fight against COVID-19","volume":"35","author":"Dror","year":"2020","journal-title":"Eur J Epidemiol"},{"issue":"14","key":"10.1016\/j.anai.2024.01.009_bib0010","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1017\/S0033291720005188","article-title":"COVID-19 vaccine hesitancy in the UK: the Oxford coronavirus explanations, attitudes, and narratives survey (Oceans) II","volume":"52","author":"Freeman","year":"2022","journal-title":"Psychol Med"},{"issue":"13","key":"10.1016\/j.anai.2024.01.009_bib0011","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1056\/NEJMc2102131","article-title":"Delayed large local reactions to mRNA-1273 vaccine against SARS-CoV-2","volume":"384","author":"Blumenthal","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.anai.2024.01.009_bib0012","doi-asserted-by":"crossref","first-page":"16","DOI":"10.3390\/vaccines9010016","article-title":"Confidence and receptivity for COVID-19 vaccines: A rapid systematic review","volume":"9","author":"Lin","year":"2020","journal-title":"Vaccines"},{"key":"10.1016\/j.anai.2024.01.009_bib0013","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.bbi.2021.03.008","article-title":"Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study","volume":"94","author":"Robertson","year":"2021","journal-title":"Brain Behav Immun"},{"issue":"8","key":"10.1016\/j.anai.2024.01.009_bib0014","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1093\/cid\/ciab633","article-title":"Deliberation, dissent, and distrust: understanding distinct drivers of coronavirus disease 2019 vaccine hesitancy in the United States","volume":"74","author":"Tram","year":"2022","journal-title":"Clin Infect Dis"},{"issue":"8","key":"10.1016\/j.anai.2024.01.009_bib0015","doi-asserted-by":"crossref","DOI":"10.1001\/jamahealthforum.2021.2103","article-title":"Youth perceptions of vaccination for COVID-19 in the United States","volume":"2","author":"Gorga","year":"2021","journal-title":"JAMA Health Forum"},{"key":"10.1016\/j.anai.2024.01.009_bib0016","doi-asserted-by":"crossref","first-page":"n513","DOI":"10.1136\/bmj.n513","article-title":"Covid-19 vaccine hesitancy among ethnic minority groups","volume":"372","author":"Razai","year":"2021","journal-title":"BMJ"},{"issue":"8","key":"10.1016\/j.anai.2024.01.009_bib0017","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1038\/s41591-021-01454-y","article-title":"COVID-19 vaccine acceptance and hesitancy in low- and middle-income countries","volume":"27","author":"Sol\u00eds Arce","year":"2021","journal-title":"Nat Med"},{"issue":"1","key":"10.1016\/j.anai.2024.01.009_bib0018","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/all.15447","article-title":"Urticaria and\/or angioedema secondary to mRNA COVID-19 vaccines: updates from a United States case registry","volume":"78","author":"Anvari","year":"2023","journal-title":"Allergy"},{"issue":"11","key":"10.1016\/j.anai.2024.01.009_bib0019","doi-asserted-by":"crossref","first-page":"e721","DOI":"10.1111\/jdv.17498","article-title":"Pityriasis rosea developing after COVID-19 vaccination","volume":"35","author":"Marcantonio-Santa Cruz","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"2","key":"10.1016\/j.anai.2024.01.009_bib0020","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1111\/bjd.20404","article-title":"Pernio after COVID-19 vaccination","volume":"185","author":"Lopez","year":"2021","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.anai.2024.01.009_bib0021","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jaci.2021.06.026","article-title":"Subepidermal blistering eruptions, including bullous pemphigoid, following COVID-19 vaccination","volume":"148","author":"Tomayko","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"10.1016\/j.anai.2024.01.009_bib0022","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.jaad.2021.03.092","article-title":"Cutaneous reactions reported after Moderna and Pfizer COVID-19 vaccination: a registry-based study of 414 cases","volume":"85","author":"McMahon","year":"2021","journal-title":"J Am Acad Dermatol"},{"issue":"12","key":"10.1016\/j.anai.2024.01.009_bib0023","doi-asserted-by":"crossref","first-page":"e857","DOI":"10.1111\/jdv.17582","article-title":"Psoriasis exacerbation after COVID-19 vaccination: a report of 14 cases from a single centre","volume":"35","author":"Sotiriou","year":"2021","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.anai.2024.01.009_bib0024","unstructured":"Centers for Disease Control and Prevention. Interim Clinical Considerations for Use of COVID-19 Vaccines in the United States. Available at: https:\/\/www.cdc.gov\/vaccines\/covid-19\/clinical-considerations\/interim-considerations-us.html. Accessed January 23, 2024."},{"key":"10.1016\/j.anai.2024.01.009_bib0025","unstructured":"World Health Organization. WHO SAGE roadmap on uses of COVID-19 vaccines in the context of OMICRON and substantial population immunity. Available at: https:\/\/iris.who.int\/bitstream\/handle\/10665\/366671\/WHO-2019-nCoV-Vaccines-SAGE-Prioritization-2023.1-eng.pdf?sequence=1. Accessed January 23, 2024."},{"issue":"2","key":"10.1016\/j.anai.2024.01.009_bib0026","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/s41591-020-1124-9","article-title":"A global survey of potential acceptance of a COVID-19 vaccine","volume":"27","author":"Lazarus","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/j.anai.2024.01.009_bib0027","first-page":"93","article-title":"The COVID-19 vaccination acceptance\/hesitancy rate and its determinants among healthcare workers of 91 Countries: a multicenter cross-sectional study","volume":"21","author":"Askarian","year":"2022","journal-title":"Excli J"},{"key":"10.1016\/j.anai.2024.01.009_bib0028","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.770985","article-title":"COVID-19 vaccine hesitancy in the United States: a systematic review","volume":"9","author":"Yasmin","year":"2021","journal-title":"Front Public Health"},{"issue":"10","key":"10.1016\/j.anai.2024.01.009_bib0029","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1016\/j.ajic.2022.05.024","article-title":"Who has not been vaccinated, fully vaccinated, or boosted for COVID-19?","volume":"50","author":"Nguyen","year":"2022","journal-title":"Am J Infect Control"},{"issue":"10","key":"10.1016\/j.anai.2024.01.009_bib0030","doi-asserted-by":"crossref","first-page":"298","DOI":"10.3390\/tropicalmed7100298","article-title":"COVID-19 vaccine booster dose acceptance: systematic review and meta-analysis","volume":"7","author":"Abdelmoneim","year":"2022","journal-title":"Trop Med Infect Dis"},{"key":"10.1016\/j.anai.2024.01.009_bib0031","doi-asserted-by":"crossref","first-page":"06008","DOI":"10.7189\/jogh.13.06008","article-title":"Global incidence pattern and factors associated with common cutaneous reactions related to COVID-19 vaccination of 2.55 million participants in real-world settings: a systematic review and meta-analysis","volume":"13","author":"Guo","year":"2023","journal-title":"J Glob Health"},{"issue":"11","key":"10.1016\/j.anai.2024.01.009_bib0032","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1111\/jdv.18294","article-title":"Global prevalence and clinical manifestations of cutaneous adverse reactions following COVID-19 vaccination: a systematic review and meta-analysis","volume":"36","author":"Washrawirul","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"8","key":"10.1016\/j.anai.2024.01.009_bib0033","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1001\/jamadermatol.2021.2114","article-title":"Incidence of cutaneous reactions after messenger RNA COVID-19 vaccines","volume":"157","author":"Robinson","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"8","key":"10.1016\/j.anai.2024.01.009_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0272691","article-title":"Hesitancy and reactogenicity to mRNA-based COVID-19 vaccines-Early experience with vaccine rollout in a multi-site healthcare system","volume":"17","author":"Al-Obaydi","year":"2022","journal-title":"PLoS One"},{"issue":"8","key":"10.1016\/j.anai.2024.01.009_bib0035","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1016\/j.jaip.2021.05.031","article-title":"Allergic symptoms after mRNA COVID-19 vaccination and risk of incomplete vaccination","volume":"9","author":"Robinson","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"11","key":"10.1016\/j.anai.2024.01.009_bib0036","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.3390\/vaccines10111777","article-title":"What contributes to COVID-19 vaccine hesitancy? A systematic review of the psychological factors associated with COVID-19 vaccine hesitancy","volume":"10","author":"Romate","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"3","key":"10.1016\/j.anai.2024.01.009_bib0037","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jaip.2022.12.010","article-title":"Urticaria after COVID-19 vaccination and vaccine hesitancy","volume":"11","author":"Judd","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"10.1016\/j.anai.2024.01.009_bib0038","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.jiph.2023.01.020","article-title":"Implications for COVID-19 vaccine uptake: a systematic review","volume":"16","author":"Adu","year":"2023","journal-title":"J Infect Public Health"},{"issue":"31","key":"10.1016\/j.anai.2024.01.009_bib0039","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1016\/j.vaccine.2022.04.097","article-title":"Factors affecting COVID-19 vaccine hesitancy among healthcare providers in 23 countries","volume":"40","author":"Leigh","year":"2022","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.anai.2024.01.009_bib0040","doi-asserted-by":"crossref","first-page":"e210","DOI":"10.1016\/S2468-2667(21)00012-8","article-title":"COVID-19 vaccine hesitancy in a representative working-age population in France: a survey experiment based on vaccine characteristics","volume":"6","author":"Schwarzinger","year":"2021","journal-title":"Lancet Public Health"},{"issue":"2","key":"10.1016\/j.anai.2024.01.009_bib0041","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41591-022-02185-4","article-title":"A survey of COVID-19 vaccine acceptance across 23 countries in 2022","volume":"29","author":"Lazarus","year":"2023","journal-title":"Nat Med"},{"issue":"11","key":"10.1016\/j.anai.2024.01.009_bib0042","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.3390\/vaccines10111791","article-title":"The Correlates & Public Health Consequences of Prospective Vaccine Hesitancy among Individuals Who Received COVID-19 Vaccine Boosters in the U.S","volume":"10","author":"Motta","year":"2022","journal-title":"Vaccines (Basel)"},{"issue":"1","key":"10.1016\/j.anai.2024.01.009_bib0043","doi-asserted-by":"crossref","first-page":"12435","DOI":"10.1038\/s41598-022-16572-x","article-title":"Characteristics associated with COVID-19 vaccine hesitancy","volume":"12","author":"Borga","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/j.anai.2024.01.009_bib0044","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jebo.2015.01.004","article-title":"Risk attitude and cognitive aging","volume":"112","author":"Bonsang","year":"2015","journal-title":"J Econ Behav Organ"},{"issue":"2","key":"10.1016\/j.anai.2024.01.009_bib0045","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1023\/A:1011109625844","article-title":"Estimating risk attitudes using lotteries: a large sample approach","volume":"22","author":"Donkers","year":"2001","journal-title":"J Risk Uncertainty"},{"issue":"8","key":"10.1016\/j.anai.2024.01.009_bib0046","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1037\/hea0001256","article-title":"COVID-19 vaccination hesitancy in adults in the United Kingdom: barriers and facilitators to uptake","volume":"42","author":"Husted","year":"2023","journal-title":"Health Psychol"},{"issue":"2","key":"10.1016\/j.anai.2024.01.009_bib0047","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11102-019-01013-2","article-title":"Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider","volume":"23","author":"Geer","year":"2020","journal-title":"Pituitary"},{"issue":"1","key":"10.1016\/j.anai.2024.01.009_bib0048","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s13075-016-1004-3","article-title":"Discordance between patient and physician assessments of global disease activity in rheumatoid arthritis and association with work productivity","volume":"18","author":"Smolen","year":"2016","journal-title":"Arthritis Res Ther"},{"issue":"1","key":"10.1016\/j.anai.2024.01.009_bib0049","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1097\/00000441-200607000-00004","article-title":"The influence of discordance in pain assessment on the functional status of patients with chronic nonmalignant pain","volume":"332","author":"Panda","year":"2006","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.anai.2024.01.009_bib0050","unstructured":"Centers for Disease Control and Prevention. Allergic reactions after COVID-19 vaccinations. Available at: https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/vaccines\/safety\/allergic-reaction.html. Accessed January 23, 2024."},{"issue":"2","key":"10.1016\/j.anai.2024.01.009_bib0051","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/13548506.2022.2084123","article-title":"Race, ethnicity, psychological factors, and COVID-19 vaccine hesitancy during the COVID-19 pandemic","volume":"28","author":"Yuan","year":"2023","journal-title":"Psychol Health Med"},{"issue":"6","key":"10.1016\/j.anai.2024.01.009_bib0052","doi-asserted-by":"crossref","first-page":"973","DOI":"10.3390\/vaccines10060973","article-title":"The health belief model applied to COVID-19 vaccine hesitancy: a systematic review","volume":"10","author":"Limbu","year":"2022","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.anai.2024.01.009_bib0053","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.711066","article-title":"Health belief model, theory of planned behavior, or psychological antecedents: what predicts COVID-19 vaccine hesitancy better among the Bangladeshi adults?","volume":"9","author":"Hossain","year":"2021","journal-title":"Front Public Health"},{"issue":"6","key":"10.1016\/j.anai.2024.01.009_bib0054","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1177\/01410768211018951","article-title":"COVID-19 vaccine hesitancy: the five Cs to tackle behavioural and sociodemographic factors","volume":"114","author":"Razai","year":"2021","journal-title":"J R Soc Med"}],"container-title":["Annals of Allergy, Asthma & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624000103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1081120624000103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,17]],"date-time":"2024-10-17T05:08:30Z","timestamp":1729141710000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1081120624000103"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":54,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1081120624000103"],"URL":"https:\/\/doi.org\/10.1016\/j.anai.2024.01.009","relation":{},"ISSN":["1081-1206"],"issn-type":[{"value":"1081-1206","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The impact of COVID-19 vaccine reactions on secondary vaccine hesitancy","name":"articletitle","label":"Article Title"},{"value":"Annals of Allergy, Asthma & Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.anai.2024.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}